• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为强效阿片类药物的C-烷基化螺[苯并呋喃-3(2H),4'-1'-甲基-哌啶-7-醇]:构效关系研究

C-alkylated spiro[benzofuran-3(2H),4'-1'-methyl-piperidine-7-ols] as potent opioids: a conformation-activity study.

作者信息

Tsai Y C, Liou J P, Liao R, Cheng C Y, Tao P L

机构信息

Institute of Pharmaceutical Sciences, College of Medicine, National Taiwan University, Taipei, Taiwan.

出版信息

Bioorg Med Chem Lett. 1998 Jul 21;8(14):1813-8. doi: 10.1016/s0960-894x(98)00318-7.

DOI:10.1016/s0960-894x(98)00318-7
PMID:9873439
Abstract

Among a series of C-alkylated analogs of the weak mu opioid ligand spiro[benzofuran-3(2H),4'-1'-methylpiperidine-7-ol] (1), the 2-methyl, 2-ethyl, and cis 3'-methyl analogs, namely compounds (+/-)2, (+/-)-3, and (+/-)-4, showed much enhanced mu-affinities, with (+/-)-4 being almost as potent as (-)-morphine; while the trans 3'-methyl analog (+/-)-5 remained a weak mu-binder. Energy calculations and nmr data indicated that compounds 2-4 favor phenyl-axial conformations, while compounds 1 and 5 favor phenyl-equatorial conformations.

摘要

在弱μ阿片样物质配体螺苯并呋喃-3(2H),4'-1'-甲基哌啶-7-醇的一系列C-烷基化类似物中,2-甲基、2-乙基和顺式3'-甲基类似物,即化合物(±)2、(±)-3和(±)-4,显示出显著增强的μ亲和力,其中(±)-4几乎与(-)-吗啡一样有效;而反式3'-甲基类似物(±)-5仍然是一种弱μ结合剂。能量计算和核磁共振数据表明,化合物2-4有利于苯基轴向构象,而化合物1和5有利于苯基赤道构象。

相似文献

1
C-alkylated spiro[benzofuran-3(2H),4'-1'-methyl-piperidine-7-ols] as potent opioids: a conformation-activity study.作为强效阿片类药物的C-烷基化螺[苯并呋喃-3(2H),4'-1'-甲基-哌啶-7-醇]:构效关系研究
Bioorg Med Chem Lett. 1998 Jul 21;8(14):1813-8. doi: 10.1016/s0960-894x(98)00318-7.
2
Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.吗啡片段的构效关系研究。I. 4-烷基-4-(间羟基苯基)哌啶
Mol Pharmacol. 1988 Sep;34(3):363-76.
3
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.
J Med Chem. 1993 Oct 1;36(20):2833-41. doi: 10.1021/jm00072a001.
4
Synthesis, stereochemistry, and biological activity of the 1-(1-phenyl-2-methylcyclohexyl)piperidines and the 1-(1-phenyl-4-methylcyclohexyl)piperidines. Absolute configuration of the potent trans-(-)-1-(1-phenyl-2-methylcyclohexyl)piperidine.1-(1-苯基-2-甲基环己基)哌啶和1-(1-苯基-4-甲基环己基)哌啶的合成、立体化学及生物活性。强效反式-(-)-1-(1-苯基-2-甲基环己基)哌啶的绝对构型。
J Med Chem. 1991 Aug;34(8):2615-23. doi: 10.1021/jm00112a041.
5
Structure activity studies of a series of 4-(m-OH phenyl) piperidines.
NIDA Res Monogr. 1986;75:49-52.
6
Synthesis and structure-activity relationships of a new series of 2alpha-substituted trans-4,5-dimethyl-4-(3-hydroxyphenyl)piperidine as mu-selective opioid antagonists.
Bioorg Med Chem Lett. 2006 Feb 15;16(4):864-8. doi: 10.1016/j.bmcl.2005.11.010. Epub 2005 Nov 18.
7
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.N-取代反式-3,4-二甲基-4-(3-羟基苯基)哌啶类μ-阿片受体拮抗剂生物活性构象的阐明。
J Med Chem. 2006 Dec 14;49(25):7278-89. doi: 10.1021/jm060486f.
8
Design and synthesis of 4-phenyl piperidine compounds targeting the mu receptor.
Bioorg Med Chem Lett. 2004 Nov 1;14(21):5275-9. doi: 10.1016/j.bmcl.2004.08.032.
9
Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.在4-[(N-取代-4-哌啶基)芳氨基]-N,N-二乙基苯甲酰胺的构效关系研究中揭示了影响阿片δ受体激动剂效力和选择性的因素。
J Med Chem. 2001 Mar 15;44(6):972-87. doi: 10.1021/jm000427g.
10
Novel trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines as mu opioid receptor antagonists with improved opioid receptor selectivity profiles.新型反式-3,4-二甲基-4-(3-羟基苯基)哌啶类化合物作为μ阿片受体拮抗剂,具有改善的阿片受体选择性谱。
Bioorg Med Chem Lett. 2008 Mar 15;18(6):2006-12. doi: 10.1016/j.bmcl.2008.01.106. Epub 2008 Feb 2.